BLAIR WILLIAM & CO/IL - CTI BIOPHARMA CORP ownership

CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 40 filers reported holding CTI BIOPHARMA CORP in Q3 2020. The put-call ratio across all filers is 0.21 and the average weighting 0.5%.

Quarter-by-quarter ownership
BLAIR WILLIAM & CO/IL ownership history of CTI BIOPHARMA CORP
ValueSharesWeighting
Q1 2023$556,135
-30.1%
132,4130.0%0.00%
-33.3%
Q4 2022$795,802
-22.4%
132,413
-24.8%
0.00%
-40.0%
Q3 2022$1,025,000
-2.6%
176,1980.0%0.01%0.0%
Q2 2022$1,052,000
+27.8%
176,1980.0%0.01%
+66.7%
Q1 2022$823,000
+20.1%
176,198
-36.2%
0.00%
+50.0%
Q4 2021$685,000
+31.7%
276,198
+56.8%
0.00%0.0%
Q3 2021$520,000
+173.7%
176,198
+131.2%
0.00%
+100.0%
Q2 2021$190,000
-14.4%
76,1980.0%0.00%0.0%
Q1 2021$222,000
-9.4%
76,1980.0%0.00%0.0%
Q4 2020$245,000
+49.4%
76,198
-0.0%
0.00%0.0%
Q3 2020$164,000
+86.4%
76,2110.0%0.00%
Q2 2020$88,000
+25.7%
76,2110.0%0.00%
Q1 2020$70,000
-13.6%
76,211
+48.8%
0.00%
Q4 2019$81,000
+88.4%
51,2110.0%0.00%
Q3 2019$43,000
-2.3%
51,211
+0.0%
0.00%
Q2 2019$44,000
-12.0%
51,1980.0%0.00%
Q1 2019$50,000
+31.6%
51,1980.0%0.00%
Q4 2018$38,000
-65.8%
51,1980.0%0.00%
-100.0%
Q3 2018$111,000
-56.5%
51,1980.0%0.00%
-50.0%
Q2 2018$255,000
+86.1%
51,1980.0%0.00%
+100.0%
Q4 2017$137,000
-18.9%
51,1980.0%0.00%0.0%
Q2 2017$169,000
-21.8%
51,1980.0%0.00%
-50.0%
Q1 2017$216,00051,1980.00%
Other shareholders
CTI BIOPHARMA CORP shareholders Q3 2020
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 6,535,674$27,449,8319.21%
Bleichroeder LP 3,893,730$16,353,6663.49%
AIGH Capital Management LLC 2,100,000$8,820,0003.25%
Ally Bridge Group (NY) LLC 550,000$2,310,0003.03%
Ghost Tree Capital, LLC 2,000,000$8,400,0002.48%
Bain Capital Life Sciences Investors, LLC 4,702,996$19,7532.47%
Altium Capital Management LP 850,000$3,570,0001.98%
Parkman Healthcare Partners LLC 1,753,630$7,365,2461.60%
BVF INC/IL 8,813,021$37,014,6881.35%
Sio Capital Management, LLC 526,239$2,210,2041.09%
View complete list of CTI BIOPHARMA CORP shareholders